9amHealth

9amHealth

Private
Encinitas, CaliforniaHealthcare & Life Scienceshttps://www.join9am.com

Last Round

Series B

May 13, 2026

Est. Valuation

$155M

Total Funding Raised

$67.5M

Momentum Score

50 /100

Company Overview

9amHealth is a virtual-first healthcare provider specializing in cardiometabolic health. The company offers a comprehensive, whole-body approach to prevent and treat conditions such as diabetes, obesity, high cholesterol, and hypertension. 9amHealth partners with employers and health plans to provide its services as a benefit, which includes personalized care plans, prescription medication delivery, at-home lab tests, and unlimited access to a team of specialists including doctors, nutritionists, and pharmacists. Founded in 2021 by the team that created mySugr, the company aims to make chronic condition management more affordable, accessible, and convenient for patients across the United States.

Sector

Healthcare & Life Sciences

Verticals

Telemedicine, Patient Engagement, Vertical SaaS, Medical Devices

Business Model

B2B

Customer Profile

Subscription SaaS, Hardware + Subscription

AI Layer

Non-AI

Keywords

cardiometabolic carevirtual caretelehealthdiabetes managementobesity carechronic condition managementGLP-1sprescription medication deliveryat-home lab testingvirtual clinicweight loss programemployer health benefitsPBMspharmacy benefit managersdirect-to-consumer healthcareDTC healthcarePMPMper-member-per-monthhypertension care

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

9amHealth Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

9amHealth Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series BMay 13, 2026
Early Stage VCApr 6, 2026
Series AFeb 20, 2024
Series AApr 13, 2022

Key People

Founding team and executive leadership

Bernhard Schandl

Co-Founder CTO

Founding Team

Paul Geevarghese

Co-Founder COO

Founding Team

Anton Kittelberger

Co-Founder Co-CEO

Founding Team

Michael Hofner

CFO

Executive Team

9amHealth Investors

Notable investors and investment history

InvestorRounds
Human CapitalSeries A
Define VenturesSeries A, Series B
Leaps by BayerSeries A
7wire VenturesSeries B, Series A
Cigna VenturesSeries B
Founders FundSeries A
Catalio Capital ManagementSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 13, 2026

    $26M round led by Define Ventures.

  • Apr 6, 2026

    $26M raised in early stage VC funding.

9amHealth Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

9amHealth Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about 9amHealth's valuation, stock price, and market status.

Firmographic Details

HeadquartersEncinitas, California
Employee Range108
Year Founded2021
Last FundingMay 13, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.